ticlopidine

网络  噻氯匹定; 噻氯匹啶; 噻氯吡啶; 抵克力得; 抵克立得

化学



双语例句

  1. OBJECTIVE: To provide information for clinical rational usage of ticlopidine and clopidogrel.
    前言:目的:为临床合理使用噻氯吡定和氯吡格雷提供参考。
  2. Objective To learn the security of ticlopidine by observing its short-term adverse effect in treating patients with coronary atherosclerotic heart disease.
    目的本文观察应用噻氯匹定治疗冠心病中患者的短期不良反应,以了解噻氯匹定的安全性。
  3. AIM: To compare the efficacy and safety of clopidogrel on anti platelet aggregation with ticlopidine.
    比较阿司匹林和噻氯匹啶预防脑卒中复发的长期药物经济学效果。
  4. Objective: A HPLC method for quantitative determination of Ticlopidine hydrochloride tablets has been developed.
    目的:建立盐酸噻氯匹定片的HPLC含量测定方法。
  5. AIM: To evaluate the clinical and laboratory effects of ticlopidine on granule membrane protein of platelet ( CD 62P, CD 63) in treating acute cerebral infarction ( ACI).
    目的:观察噻氯匹定对急性脑梗死的疗效及对血小板α颗粒膜蛋白(CD62P)及血小板溶酶体完整膜蛋白(CD63)的影响。
  6. Pharmacokinetics of ticlopidine capsules and tablets in healthy volunteers
    抵克力得胶囊及片剂的药动学研究
  7. Effects of Ticlopidine and Ligustrazine on Platelet Agglutination in Patients with Ischemic Cerebral Infarction
    抵克力得与川芎嗪对缺血性脑卒中血小板聚集性的影响
  8. To observe an efficacy of combination of aspirin, ticlopidine and heparin in the prevention of subacute stent thrombosis ( SST).
    目的观察阿司匹林、抵克力得和肝素预防亚急性冠状动脉支架血栓形成(SST)的有效性。
  9. Combination of asprin 、 ticlopidine 、 heparin in the prevention of subacute stent thrombosis
    阿司匹林、噻氯匹啶、肝素预防冠状动脉支架亚急性血栓形成的效果
  10. PurposeA high performance liquid chromatography ( HPLC) method for quantitative determination of Ticlopidine hydrochloride capsules had been developed.
    目的建立盐酸噻氯匹定胶囊的高效液相色谱(HPLC)含量测定方法。
  11. The Effect of Ticlopidine on Platelet Aggregation Function and Blood Viscosity
    抵克力得对血小板聚集功能及血液流变学的影响
  12. The effects of ticlopidine on platelet aggregation ( PAg) and plasma fibrinogen ( Fg) level were investigated and compared with those of acetylsalicylic acid ( ASA) in patients with coronary artery disease ( CAD).
    本研究对冠心病患者应用噻氯吡啶对血小板聚集功能(Plateletaggregation,PAg)及血浆纤维蛋白原(fibrinogen,Fg)水平的影响进行探讨并与乙酰水杨酸(acetylsalicyliaacid,ASA)进行比较。
  13. Ticlopidine is a kind of Platelet aggregation inhibitors, which is used to prevent and cure the heart, brain and other artery circulation obstacle diseases caused by the high aggregation state of blood platelets.
    噻氯匹定是一种血小板聚集抑制剂,用于防治因血小板高聚集状态引起的心、脑及其他动脉循环障碍性疾病。
  14. Inhibition of Ticlopidine to Thromboxane B_2 in Cerebral Thrombosis
    噻氯匹啶对脑血栓病人的血栓烷B2的抑制
  15. Adverse drug reaction during ticlopidine treatment
    噻氯匹定的药物不良反应概述
  16. It was also shown thai ticlopidine could significantly inhibit platelet TXB2 formation stimulated by adenosine diphosphate ( ADP).
    噻氯匹定对ADP诱导的血小板TXB2生成也有显著抑制作用。
  17. These results suggested that antiplatelet efficacy of ticlopidine was shown, in part, to inhibit arachidonic acid metabolism of platelets.
    噻氯匹定的抗血小板作用至少有部分与抑制花生四烯酸的代谢有关。
  18. Application of Clinical for Ticlopidine Inhibiting EDTA-dependent Platelet Aggregation
    噻氯匹啶抑制EDTA依赖性血小板聚集在临床中的应用
  19. Effects of ticlopidine on activation of platelet in type 2 diabetes mellitus
    噻氯匹定对2型糖尿病病人血小板活化状态的影响
  20. Ticlopidine vs aspirin in decreasing blood viscosity and anti_platelet function
    噻氯匹定和阿司匹林降低血液粘度和抗血小板作用的比较
  21. CONCLUSION: Ticlopidine is effective for treating acute cerebral infraction and decreasing the rate of platelet aggregation.
    结论:噻氯匹定可用于脑梗死急性期的治疗,抑制血小板聚集是其重要的治疗机制。
  22. Evaluation of Pharmacological Property and Clinical Application of Ticlopidine and Clopidogrel
    噻氯吡定和氯吡格雷的药理学特性与临床应用评价
  23. Effect of ticlopidine on thromboxane B_2 production by platelets
    噻氯匹定对血小板血栓烷B2生成的影响
  24. Study on the Inhibitory Effect of Ticlopidine on Platelet Aggregation
    噻氯匹啶对血小板聚集功能的抑制作用研究
  25. Objective To observe the effect of combination of aspirin, ticlopidine, low molecular weight heparin ( LMWH) in prevention of subacute stent thrombosis ( SST).
    目的观察阿司匹林、噻氯匹啶、低分子量肝素预防亚急性冠脉支架血栓形成(SST)的效果。
  26. Open sided sequential design adopted in the present study to examine the effects of short course treatment with ticlopidine no platelet aggregation induced by adenosine diphosphate ( ADP) at low doses.
    采用开放型单向序贯设计,检测了小剂量、短疗程抵克立得治疗对ADP诱导的血小板聚集性的影响。
  27. Observation of Efficacy and Safety of Aspirin and Ticlopidine on Prevention of Acute Cerebral Infarction
    阿司匹林与噻氯匹啶预防急性脑梗死的疗效与安全性观察
  28. The Clinic Study of Ticlopidine for Prevention Hypertension and Thrombosis Induced by Recombinant Human Erythropoietin
    抵克力得预防重组人类促红细胞生成素诱发顽固性高血压和血栓症的临床研究
  29. OBJECTIVE: To compare the impacts of Ligustrazine and Ticlopidine on platelet aggregation in ischemic cerebral apoplexy patients to provide an objective gist for the medication in cerebral apoplexy prevention.
    目的:比较川芎嗪与噻氯匹定对缺血性脑卒中患者血小板聚集性影响,为预防脑卒中复发用药提供客观依据。